A nitroimidazole
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Product Type

Research Area

RGW 611

Item No. 30067

Technical Information
Formal Name
4-[2-(4-nitro-1H-imidazol-1-yl)ethyl]-morpholine
CAS Number
6497-78-5
Molecular Formula
C9H14N4O3
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 5 mg/mlDMSO: 1 mg/ml
λmax
298 nm
SMILES
O=[N+](C1=CN(CCN2CCOCC2)C=N1)[O-]
InChi Code
InChI=1S/C9H14N4O3/c14-13(15)9-7-12(8-10-9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2
InChi Key
VDZAAIIQCHGJAD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    RGW 611 is a nitroimidazole.1 It enhances radiation-induced cell death of hypoxic V79-379A cells.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Adams, G.E., Clarke, E.D., Flockhart, I.R., et alStructure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 35(2), 133-150 (1979).